Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP8 | Q6V1X1 | 2/20 | 0.49 |
| ▸ | DPP9 | Q86TI2 | 2/20 | 0.49 |
| ▸ | DPP7 | Q9UHL4 | 2/20 | 0.49 |
| ▸ | GSR | P00390 | 1/20 | 0.47 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.45 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.45 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.45 |
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.44 |
| ▸ | DPP4 | P27487 | 1/20 | 0.43 |
| ▸ | TLR2 | O60603 | 1/20 | 0.43 |
| ▸ | MMP2 | P08253 | 1/20 | 0.43 |
| ▸ | NPY4R | P50391 | 3/20 | 0.42 |
| ▸ | NPY1R | P25929 | 2/20 | 0.42 |
| ▸ | NPY2R | P49146 | 2/20 | 0.42 |
| ▸ | NPY5R | Q15761 | 2/20 | 0.42 |
| ▸ | SIRT6 | Q8N6T7 | 1/20 | 0.41 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29462129 | 1.00 | DPP8 (0.49) | DPP8DPP9DPP7GSRGNAI3 | |
| SCHEMBL29740503 | 1.00 | DPP8 (0.49) | DPP8DPP9DPP7GSRGNAI3 | |
| SCHEMBL29805332 | 1.00 | DPP8 (0.49) | DPP8DPP9DPP7GSRGNAI3 | |
| SCHEMBL31325363 | 1.00 | DPP8 (0.49) | DPP8DPP9DPP7GSRGNAI3 | |
| SCHEMBL7570529 | 0.97 | DPP8 (0.51) | DPP8DPP9DPP7GSRGNAI3 | |
| SCHEMBL27584028 | 0.95 | DPP8 (0.50) | DPP8DPP9DPP7GSRGNAI3 | |
| SCHEMBL27562795 | 0.95 | DPP8 (0.50) | DPP8DPP9DPP7GSRGNAI3 | |
| SCHEMBL30399386 | 0.93 | NOD1 (0.45) | DPP8DPP9DPP7GSRGNAI3 | |
| SCHEMBL27481469 | 0.91 | DPP7 (0.50) | DPP8DPP9DPP7GSRGNAI3 | |
| SCHEMBL27498622 | 0.91 | DPP7 (0.50) | DPP8DPP9DPP7GSRGNAI3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250129122-A1 | PEPTIDE, AND CELL FUSION AGENT AND PHARMACEUTICAL COMPOSITION FOR CANCER THERAPY CONTAINING SAID PEPTIDE | KOGA MICHIKO (JP) | 2025-04-24 | — | — | US | disclosed |
| WO-2022202785-A1 | PEPTIDE, AND CELL FUSION AGENT AND PHARMACEUTICAL COMPOSITION FOR CANCER THERAPY CONTAINING SAID PEPTIDE | 甲賀 美智子 | 2022-09-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250129122-A1 | PEPTIDE, AND CELL FUSION AGENT AND PHARMACEUTICAL COMPOSITION FOR CANCER THERAPY CONTAINING SAID PEPTIDE | VIP, ARGLU1, NGLY1 | DPP8 897/4885DPP9 846/4885DPP7 1301/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.